The 8th World Drug Discovery & Development Summit 2008
2nd & 3rd December 2008
Prague Congress Centre, Prague, Czech Republic
Advisory Board
We work closely with a chosen panel of leading experts and practitioners to put together a timely relevant programme which truly reflects today’s key industry concerns and are constantly seeking industry feedback and new contacts to join the advisory board. Members meet a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.
The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.
Current WDD Advisory Board Members Include:
 |
Dr. Lee Babiss Head of Global Pharma Research, Hoffmann-La Roche, Ltd Switzerland |
 |
Dr. David De Graaf Director of Systems Biology Pfizer Research Technology Center (RTC) USA |
 |
Dr. Neil Weir Senior Vice President, Global Research, UCB Celltech UK |
 |
Dr. Orest Hurko Assistant Vice President for Clinical Discovery, Translational Research Wyeth USA |
 |
Prof. Ian Wilson Senior Principal Scientist AstraZeneca UK |
 |
Dr. Jinghai J. Xu Director of Automated Biotechnology Merck & Co USA |
Application for membership
We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact: Gemma Fuller, Conference Producer, Life Science Division, World Trade Group , T: +44 (0) 20 7202 7500
Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.
